Increased Expression of Soluble Cytotoxic T‐Lymphocyte‐Associated Antigen‐4 Molecule in Patients with Systemic Lupus Erythematosus
Data up to Jan 2025
Total Citations Per Year
Abstract
References (12)
The 1982 revised criteria for the classification of systemic lupus erythematosus
1982 • 14,553 citations
Derivation of the sledai. A disease activity index for lupus patients
1992 • 4,410 citations
CD28/B7 SYSTEM OF T CELL COSTIMULATION
1996 • 2,726 citations
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.
1996 • 917 citations
CTLA-4 ligation blocks CD28-dependent T cell activation.
1996 • 787 citations
CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location.
1991 • 422 citations
CTLA-4: a negative regulator of autoimmune disease.
1996 • 382 citations
A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells
1999 • 257 citations
A Native Soluble Form of CTLA-4
2000 • 238 citations
Cutting Edge: A Soluble Form of CTLA-4 in Patients with Autoimmune Thyroid Disease
2000 • 227 citations
An Mse I RFLP in the Human CTLA4 Promotor
1996 • 150 citations
Expression of CTLA-4 molecule in peripheral blood T lymphocytes from patients with systemic lupus erythematosus.
1998 • 30 citations